Key result
In a survey of 929 patients with rheumatoid arthritis, influenza vaccination uptake was 85.9% while pneumococcal vaccination uptake was only 44.3%, and pneumococcal vaccination was associated with a non-significant reduction in hospital admissions for infection.
Cross-Sectional (n=929)
Yes
In UK patients with rheumatoid arthritis, influenza vaccination uptake is high but pneumococcal vaccination rates remain poor, highlighting a need for improved collaborative care to mitigate infection risks.
Answers are grounded in this paper and cite their sources.
Pneumococcal vaccination uptake lags in RA; cross-sectional data leave reduction in infection admissions open.
BACKGROUND: Infections are a common complication of RA with associated morbidity and mortality. The aetiology of increased risk is complex and multifactorial. Despite this, strategies to mitigate against risk of infection including vaccination are not always addressed in primary or secondary care with wide variation in practice from multiple small single centre audits. This study was a large two-centre survey of vaccine uptake in routine clinical practice and evaluated the relationship between vaccination and the burden of infection in RA patients. METHODS: A patient questionnaire was devised and disseminated through postal, clinic and phone survey at 2 UK rheumatology centres, detailing past vaccination history, reasons for non-vaccination, and history of recent infection. In a subset of patients, primary care vaccination data were also obtained. RESULTS: In total 929 patients responded to the survey. Over 85 % of patients were vaccinated against influenza, however only 44 % were vaccinated against pneumococcus. The vast majority of vaccination was undertaken in primary care. In the 12 months prior to the survey, 7.7 % of subjects recalled at least one episode of severe infection requiring admission, and nearly 40 % reported receiving at least one course of antibiotics. CONCLUSIONS: Infections are common in RA and Rheumatologists need to be adept at recognising at risk patients and managing them appropriately. Influenza vaccination uptake is good whilst pneumococcal vaccination rates are comparatively poor. Collaborative approaches between primary and secondary care are required to maximise vaccine uptake, which is safe and recommended in RA patients.
No takes yet. Share an insight, caveat, or question.
Subesinghe et al. (2016) conducted a cross-sectional in Rheumatoid arthritis (n=929). Pneumococcal vaccination vs. No pneumococcal vaccination was evaluated on Hospital admission with infection in the preceding year (OR 0.61, 95% CI 0.37-1.03). In a survey of 929 patients with rheumatoid arthritis, influenza vaccination uptake was 85.9% while pneumococcal vaccination uptake was only 44.3%, and pneumococcal vaccination was associated with a non-significant reduction in hospital admissions for infection.
Synapse has enriched 10 related papers. Consider them for comparative context: